# DESCRIPTION

## BACKGROUND

- introduce C. trachomatis
- discuss current treatment limitations
- highlight importance of CD4+ T-cells
- motivate need for vaccine

## SUMMARY

- summarize invention

## DETAILED DESCRIPTION

- introduce Chlamydia vaccines with vault-based carrier
- describe vault structure and composition
- detail vault proteins and untranslated RNA molecules
- describe VPARP and its poly ADP-ribosylation activity
- provide embodiment of vault-like particle for sequestering substances
- provide embodiment of vault-like particle as carrier molecule
- describe vaccine compositions with immunogenic peptide and vault-like particle
- detail immunogenic peptides, including MOMP and variants
- describe methods for identifying homologues of immunogenic peptides
- define protective immunity and active/passive immune responses
- describe cell-mediated and antibody immune responses
- explain theory of enhanced immunogenicity with vault-like particles
- provide methods for delivering substances with vault-like particles
- describe targeting moieties, including Fc binding domain
- provide methods for treating/preventing Chlamydia infection and disease
- describe methods for immunizing against Chlamydia infection
- provide kits for immunizing against Chlamydia infection
- define MVP without VPARP, TEP1 and vRNA
- define MVP with VPARP or TEP1 or vRNA
- define modified MVP
- define human
- define organism, tissue, cell and environmental medium
- define administering
- define MS2
- define comprise
- describe method of using naturally occurring vaults
- describe method of making vault-like particles
- describe modifications to MVP
- describe modifications to VPARP
- describe modifications to TEP1
- describe modifications to vRNA
- describe adding substance-binding domains to MVP
- describe adding immunogenic peptides to MVP
- describe adding heavy metal binding domains to MVP
- describe adding polynucleotide-binding domains to MVP
- provide vault-like particles
- modify MVP with immunogenic peptides
- modify MVP with receptor-binding domains
- modify MVP with eukaryotic cell receptor-binding domains
- modify MVP with substance-binding domains
- modify MVP with sensor domains
- modify MVP with multiple domains
- modify MVP with GAL4 and receptor-binding domains
- modify MVP with MS2 and receptor-binding domains
- modify MVP with polylysine and receptor-binding domains
- provide vault-like particles with modified MVP
- provide vault-like particles with immunogenic peptides
- provide vault-like particles with receptor-binding domains
- provide vault-like particles with multiple modifications
- define vault-like particles
- describe method of preventing damage
- describe method of delivering substance
- describe method of delivering sensor
- describe method of detecting signal
- describe method of making vault-like particles
- describe method of making vault-like particles with substance
- describe modifications to MVP and VPARP
- describe embodiments of vault-like particles

## EXAMPLES

### Example 1

- prepare chlamydia-vault-like particles (CVLPs)
- express MOMP-INT construct in sf9 insect cells
- purify vaults and incorporate MOMP-INT
- analyze CVLPs by Western blot and silver staining
- demonstrate MOMP-INT incorporation into vaults

### Example 2

- immunize mice with CVLPs
- analyze immune response by flow cytometry
- measure bacterial burden after intravaginal challenge
- demonstrate protective immunity against chlamydial infection
- analyze Th1 cell response by flow cytometry
- measure antibody response by ELISA
- demonstrate reduced inflammation in genital tract
- describe immunization and challenge protocols

### Example 3

- evaluate vault-induced endocytosis by dendritic cells
- demonstrate internalization of vaults by immature BMDCs

### Example 4

- introduce immunization with peptide containing vaults
- measure serum antibody levels in mice
- analyze antibody development against vaults
- describe antibodies and flow cytometry methods
- describe novel vaccine platform and its advantages
- discuss alternative interpretations and scope of invention

